Oklahoma awaits opponent for NBA semifinal 2026 https://lrivo.com/oklahoma-awaits-opponent-for-nba-semifinal-2026
Thunder reach Western Finals after 4-0 sweep of Lakers. Who will be the opponent — Spurs or Minnesota? All scenarios, statistics, and match preview.
Russian stocks await Power of Siberia-2: market analysis https://ymaho.com/russian-stocks-await-power-of-siberia-2-market-analysis
How Putin's visit to China and negotiations on the Power of Siberia-2 gas pipeline will affect the Moscow Exchange index. Find out the forecast and which stocks can make money.
Forint strengthens by 8%: markets await EU fund unlocking https://ymaho.com/forint-strengthens-by-8-markets-await-eu-fund-unlocking
Hungarian forint rises 8% after opposition victory. Learn how the change of power in Hungary will unlock access to €17 billion from the EU and what will happen to the exchange rate next.
US considers strikes on Iran: markets await escalation https://ymaho.com/us-considers-strikes-on-iran-markets-await-escalation
Analysis of the probability of new US strikes on Iran, impact on oil, dollar and stock markets. Forecast for 72 hours. Read details.
Ekitike Injury Scare: Achilles Scan Results Awaited https://lrivo.com/ekitike-injury-scare-achilles-scan-results-awaited
Hugo Ekitike faces potential Achilles rupture after collapsing vs PSG. Impact on Liverpool & France World Cup hopes explained. Read latest update.
Bitcoin freezes at $77,000 ahead of Fed rate decision https://ymaho.com/bitcoin-freezes-at-77-000-ahead-of-fed-rate-decision
BTC consolidates awaiting Fed verdict. Key resistance — $78,000-$79,500. Find out why the market is pricing in a hawkish scenario and how the change of Fed chair to Kevin Warsh on May 15 will affect crypto.
Intellia CRISPR therapy: phase 3 data on edema — breakthrough https://ymaho.com/intellia-crispr-therapy-phase-3-data-on-edema-breakthrough
Intellia presented long-awaited phase III data of CRISPR therapy lonvo-z for hereditary angioedema: 87% reduction in attacks, 62% of patients attack-free. Learn about the breakthrough in in vivo genome editing.
CRISPR Therapy HAE: Phase 3 Data from Intellia at EAACI 2026 https://ymaho.com/crispr-therapy-hae-phase-3-data-from-intellia-at-eaaci-2026
Intellia presented the long-awaited results of phase 3 of CRISPR therapy lonvoguran ziclumeran for hereditary angioedema. Reduction of attacks by 87%, 62% of patients without therapy. Learn more.
US-Iran Truce: What Lies Behind Trump's Statement https://ymaho.com/us-iran-truce-what-lies-behind-trump-s-statement
Analysis of US-Iran Negotiations: Why Trump Awaits a Response, the Essence of Disagreements on the Nuclear Deal, and Who Benefits from the Conflict. Read the Hidden Details.
Jordy Clasie's AZ Comeback: Injury, Surgery Delay & Recovery https://lrivo.com/jordy-clasie-s-az-comeback-injury-surgery-delay-recovery
AZ Alkmaar's Jordy Clasie discusses his long-awaited return from ankle injury, admitting a mistake in delaying surgery. Learn about his recovery journey and lessons learned.